224 related articles for article (PubMed ID: 33886060)
21. Suppression of CpG-ODN-mediated IFNα and TNFα response in human plasmacytoid dendritic cells (pDC) by cannabinoid receptor 2 (CB2)-specific agonists.
Henriquez JE; Crawford RB; Kaminski NE
Toxicol Appl Pharmacol; 2019 Apr; 369():82-89. PubMed ID: 30807757
[TBL] [Abstract][Full Text] [Related]
22. The cannabinoid CB2 receptor-specific agonist AM1241 increases pentylenetetrazole-induced seizure severity in Wistar rats.
de Carvalho CR; Hoeller AA; Franco PL; Martini AP; Soares FM; Lin K; Prediger RD; Whalley BJ; Walz R
Epilepsy Res; 2016 Nov; 127():160-167. PubMed ID: 27608434
[TBL] [Abstract][Full Text] [Related]
23. Cannabinoid CB2 receptor activation attenuates cytokine-evoked mucosal damage in a human colonic explant model without changing epithelial permeability.
Harvey BS; Nicotra LL; Vu M; Smid SD
Cytokine; 2013 Aug; 63(2):209-17. PubMed ID: 23706402
[TBL] [Abstract][Full Text] [Related]
24. The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells.
Greenhough A; Patsos HA; Williams AC; Paraskeva C
Int J Cancer; 2007 Nov; 121(10):2172-80. PubMed ID: 17583570
[TBL] [Abstract][Full Text] [Related]
25. In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor?
Yao BB; Mukherjee S; Fan Y; Garrison TR; Daza AV; Grayson GK; Hooker BA; Dart MJ; Sullivan JP; Meyer MD
Br J Pharmacol; 2006 Sep; 149(2):145-54. PubMed ID: 16894349
[TBL] [Abstract][Full Text] [Related]
26. Expression of cannabinoid 1 and, 2 receptors and the effects of cannabinoid 1 and, 2 receptor agonists on detrusor overactivity associated with bladder outlet obstruction in rats.
Kim SD; Cho KJ; Kim JC
BMC Urol; 2017 Dec; 17(1):121. PubMed ID: 29284441
[TBL] [Abstract][Full Text] [Related]
27. Anti-Inflammatory Activity of a CB2 Selective Cannabinoid Receptor Agonist: Signaling and Cytokines Release in Blood Mononuclear Cells.
Capozzi A; Caissutti D; Mattei V; Gado F; Martellucci S; Longo A; Recalchi S; Manganelli V; Riitano G; Garofalo T; Sorice M; Manera C; Misasi R
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011295
[TBL] [Abstract][Full Text] [Related]
28. JWH-133, a Selective Cannabinoid CB₂ Receptor Agonist, Exerts Toxic Effects on Neuroblastoma SH-SY5Y Cells.
Wojcieszak J; Krzemień W; Zawilska JB
J Mol Neurosci; 2016 Apr; 58(4):441-5. PubMed ID: 26842917
[TBL] [Abstract][Full Text] [Related]
29. Endocannabinoids modulate apoptosis in endometriosis and adenomyosis.
Bilgic E; Guzel E; Kose S; Aydin MC; Karaismailoglu E; Akar I; Usubutun A; Korkusuz P
Acta Histochem; 2017 Jun; 119(5):523-532. PubMed ID: 28549792
[TBL] [Abstract][Full Text] [Related]
30. Prospects for cannabinoid therapies in viral encephalitis.
Solbrig MV; Fan Y; Hazelton P
Brain Res; 2013 Nov; 1537():273-82. PubMed ID: 24021420
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
[TBL] [Abstract][Full Text] [Related]
32. The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro.
Luca T; Di Benedetto G; Scuderi MR; Palumbo M; Clementi S; Bernardini R; Cantarella G
Eur J Pharmacol; 2009 Aug; 616(1-3):16-21. PubMed ID: 19539619
[TBL] [Abstract][Full Text] [Related]
33. Effect of Cannabinoid Receptor Agonists on Isolated Rat Atria.
Maggo S; Ashton JC
J Cardiovasc Pharmacol; 2018 Oct; 72(4):191-194. PubMed ID: 30080756
[TBL] [Abstract][Full Text] [Related]
34. Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.
McKallip RJ; Lombard C; Fisher M; Martin BR; Ryu S; Grant S; Nagarkatti PS; Nagarkatti M
Blood; 2002 Jul; 100(2):627-34. PubMed ID: 12091357
[TBL] [Abstract][Full Text] [Related]
35. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C
PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991
[TBL] [Abstract][Full Text] [Related]
36. Cannabinoid CB
Souza CF; Borges LB; Oliveira FRMB; Silva PCS; Patricio DO; Rosales TO; Souza NF; Spiller F; Mansur DS; Assreuy J; Sordi R
Eur J Pharmacol; 2023 Nov; 959():176092. PubMed ID: 37797676
[TBL] [Abstract][Full Text] [Related]
37. Targeting the cannabinoid receptor CB2 in a mouse model of l-dopa induced dyskinesia.
Rentsch P; Stayte S; Egan T; Clark I; Vissel B
Neurobiol Dis; 2020 Feb; 134():104646. PubMed ID: 31669673
[TBL] [Abstract][Full Text] [Related]
38. Activation of cannabinoid type 2 receptor by JWH133 protects heart against ischemia/reperfusion-induced apoptosis.
Li Q; Wang F; Zhang YM; Zhou JJ; Zhang Y
Cell Physiol Biochem; 2013; 31(4-5):693-702. PubMed ID: 23711495
[TBL] [Abstract][Full Text] [Related]
39. Cannabinoid receptor 2 agonist promotes parameters implicated in mucosal healing in patients with inflammatory bowel disease.
Tartakover Matalon S; Ringel Y; Konikoff F; Drucker L; Pery S; Naftali T
United European Gastroenterol J; 2020 Apr; 8(3):271-283. PubMed ID: 32213014
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
